✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vivo Bio Tech Ltd.

VIVOBIOT

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹82 Cr.
P/E
9.71

Vivo Bio Tech Ltd.

  • Vivo Bio Tech
  • Jeevan Scientific
  • Zenotech Laboratorie

FAQs on Vivo Bio Tech Ltd. Shareprice

Vivo Bio Tech has given lower returns compared to its competitors.
Vivo Bio Tech has grown at ~-5.72% over the last 8yrs while peers have grown at a median rate of 2.78%

Vivo Bio Tech is not expensive.
Latest PE of Vivo Bio Tech is 9.71, while 3 year average PE is 19.05.
Also latest EV/EBITDA of Vivo Bio Tech is 6.23 while 3yr average is 6.35.

View FAQ's On Business

Growth Table

  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Balance Sheet

  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Cash Flow

  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Quarterly Results

  • Vivo Bio Tech Ltd.
  • Jeevan Scientific
  • Zenotech Laboratorie

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vivo Bio Tech Ltd. Financials

Vivo Bio Tech balance sheet is weak and might have solvency issues

The net debt of Vivo Bio Tech is decreasing.
Latest net debt of Vivo Bio Tech is ₹52.74 Crs as of Mar-25.
This is less than Mar-24 when it was ₹70.53 Crs.

The profit is oscillating.
The profit of Vivo Bio Tech is ₹8.45 Crs for TTM, ₹2.53 Crs for Mar 2024 and ₹2.65 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vivo Bio Tech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech